Postes actifs de Frank T. Baumgart
Sociétés | Poste | Début | Fin |
---|---|---|---|
MR confon GmbH
MR confon GmbH Medical SpecialtiesHealth Technology MR confon GmbH develops and commercializes brain imaging diagnostic products. The firm's products include headphones, earmuffs, audio-control unit, analogue converter and microphone. Its products comprise communication and active-noise-control for functional magnetic resonance imaging. The company was founded in 2001 and is headquartered in Magdeburg, Germany. | Directeur Général | - | - |
Historique de carrière de Frank T. Baumgart
Anciens postes connus de Frank T. Baumgart
Sociétés | Poste | Début | Fin |
---|---|---|---|
KeyNeurotek Pharmaceuticals AG
KeyNeurotek Pharmaceuticals AG Pharmaceuticals: OtherHealth Technology KeyNeurotek Pharmaceuticals AG is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal and autoimmune diseases. KeyNeurotek’s drug portfolio covers the entire drug development chain from research stage to advanced clinical development. At present, two compounds are in clinical development, KN38-7271 and KN203, both addressing significant markets such as traumatic brain injury, TBI, stroke, and urinary incontinence/overactive bladder. The company’s product development is based on its proprietary technology platform, which has been specifically tailored to diseases of the central nervous system, TELOMICS. KeyNeurotek was founded by Dr Frank Striggow, Frank Baumgart, Prof Dr Klaus G. Reymann and Prof Dr Henning Scheich in May 2000. The company is located in Magdeburg, Germany. | Fondateur | 31/08/2009 | 03/08/2011 |
Statistiques
Internationale
Allemagne | 3 |
Opérationnelle
Chief Executive Officer | 1 |
Founder | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
MR confon GmbH
MR confon GmbH Medical SpecialtiesHealth Technology MR confon GmbH develops and commercializes brain imaging diagnostic products. The firm's products include headphones, earmuffs, audio-control unit, analogue converter and microphone. Its products comprise communication and active-noise-control for functional magnetic resonance imaging. The company was founded in 2001 and is headquartered in Magdeburg, Germany. | Health Technology |
KeyNeurotek Pharmaceuticals AG
KeyNeurotek Pharmaceuticals AG Pharmaceuticals: OtherHealth Technology KeyNeurotek Pharmaceuticals AG is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal and autoimmune diseases. KeyNeurotek’s drug portfolio covers the entire drug development chain from research stage to advanced clinical development. At present, two compounds are in clinical development, KN38-7271 and KN203, both addressing significant markets such as traumatic brain injury, TBI, stroke, and urinary incontinence/overactive bladder. The company’s product development is based on its proprietary technology platform, which has been specifically tailored to diseases of the central nervous system, TELOMICS. KeyNeurotek was founded by Dr Frank Striggow, Frank Baumgart, Prof Dr Klaus G. Reymann and Prof Dr Henning Scheich in May 2000. The company is located in Magdeburg, Germany. | Health Technology |
- Bourse
- Insiders
- Frank T. Baumgart
- Expérience